Key Benefits

• Schizonticidal as a single dose
  
  
• Novel mode of action making Malareich effective against some strains of Plasmodium falciparum resistant to other antimalarials
  
  
• Long half-life to ensure long-term clinical and parasitological efficacy
  
  
• Severe ADRs rarely associated with the standard treatment dose
  
  
• Wide range of presentations to help with patient compliance - tablets, capsules and suspension and now, easy-to-swallow geltabs

Indications

• Treatment of malaria caused by Plasmodium falciparum